Floatz logo

Erythromycin

Platelet Storage Pool Deficiency

National Human Genome Research Institute (NHGRI)Small moleculePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Platelet Storage Pool Deficiency cohort.

Asset / SponsorPhaseRating
N-Acetyl-L-Cysteine
National Human Genome Research Institute (NHGRI)
Phase 2BB
Pirfenidone
William Gahl, M.D.
Phase 2B
Zileuton
National Human Genome Research Institute (NHGRI)
Phase 1/2CCC
Losartan
National Human Genome Research Institute (NHGRI)
Phase 1/2CCC
PRAVASTATIN
National Human Genome Research Institute (NHGRI)
Phase 1/2CCC

Same molecule, other indications

Erythromycin is also rated in:

classic familial adenomatous polyposisDormant
BB
Indicative ·
65 / 100
View asset →
colorectal cancerDormant
B
Indicative ·
57 / 100
View asset →
non-small cell lung carcinomaDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →